New research reveals that individuals who come off new slimming jabs like Wegovy and Mounjaro tend to recover reduced body mass far faster than those who halt traditional diet and exercise regimens.
Published data in a major health publication shows that while obese people can lose substantial amounts of their total mass while using the jabs, the weight comes back at an average rate of nearly a kilo each month upon discontinuation.
"People buying these medications need to be informed of the potential of quick rebound weight gain when the medication concludes," cautioned researcher Dr. Susan Jebb.
Such speed of regain means a return to original mass in about one and a half years.
Weighing Approaches
The research, which examined dozens of studies involving thousands of participants, compared the results of these new drugs with conventional dieting.
The team emphasize that individuals who lose weight through diet and exercise typically see a slower creep back—approximately 0.1 kg a month—post-intervention.
Explaining the Fast Rebound
Nutrition scientists propose the mode of action of the drugs accounts for the amplified regain.
These medications mimic a natural hormone called GLP-1, which helps regulate feelings of fullness.
"Sustained high doses of the hormone levels far above than the body's typical production may cause the body to generate a reduced amount of its own natural GLP-1, and may also reduce sensitivity to its actions," said Dr. Adam Collins, a dietetics specialist.
"Stopping of this medication results in appetite is no longer kept in check, making excessive eating much more probable."
A Lifelong Condition?
Health authorities suggest the jabs for people with weight-linked health risks, alongside recommended lifestyle changes.
Professionals contend that, given the significant potential of relapse, the therapy should be considered life-long.
This view is reinforced by pharmaceutical companies, who state that the results "underscore the long-term nature of obesity," akin to managing diseases like diabetes.
Patient Accounts
Users who have stopped the jabs explain a intense resurgence of hunger.
"It felt as if a switch flipping and you're instantly starving," recalled one woman.
The struggle is exacerbated if individuals have not developed sustainable lifestyle or habit changes during therapy.
Growing Adoption
Survey data indicate that a significant number of adults in the UK have used these injections in the past year, with interest remaining high.
- Adoption is greater among women compared to men.
- The 40s and 50s age group shows the highest level of interest.
- Many access the drugs through private prescriptions rather than public health services.
Finally, clinicians emphasize that while GLP-1 drugs are potent agents for weight loss, they are not a standalone solution and maintained weight loss relies on combined lifestyle support.